We noted you are experiencing viewing problems
-
Check with your IT department that JWPlatform, JWPlayer and Amazon AWS & CloudFront are not being blocked by your network. The relevant domains are *.jwplatform.com, *.jwpsrv.com, *.jwpcdn.com, jwpltx.com, jwpsrv.a.ssl.fastly.net, *.amazonaws.com and *.cloudfront.net. The relevant ports are 80 and 443.
-
Check the following talk links to see which ones work correctly:
Auto Mode
HTTP Progressive Download Send us your results from the above test links at access@hstalks.com and we will contact you with further advice on troubleshooting your viewing problems. -
No luck yet? More tips for troubleshooting viewing issues
-
Contact HST Support access@hstalks.com
-
Please review our troubleshooting guide for tips and advice on resolving your viewing problems.
-
For additional help, please don't hesitate to contact HST support access@hstalks.com
We hope you have enjoyed this limited-length demo
This is a limited length demo talk; you may
login or
review methods of
obtaining more access.
Printable Handouts
Navigable Slide Index
- Introduction
- Chemical world divided to oxidants/antioxidants
- Oxidants
- The lesson from Berny Babior
- The toxic oxidant cocktail
- Therapeutic approach to treat infectious diseases
- Selective inhibition of pathogen defense systems
- Trypanosomatids
- Hydroperoxide metabolism in mammals
- Trypanosomes have different oxidants metabolism
- Unique antioxidants defense in trypanosomes
- What is trypanothione?
- The search for TPx homologous to GPx
- The break through in 1997
- Oxidoreductases system components
- Comparing TXN and Trx
- How does trypanothione interact with TXN?
- Reduced and oxidized active site of TXN
- Proof of essentiality of C41 and C43 in TXN
- The tool to study interaction of TXN - T(SH)2
- Structure of TXN reacted with a pseudo-substrate
- First steps of the catalytic cycle
- Information from site-directed mutagenesis of TXN
- Tryparedoxin in action
- Unusual mechanism: the "perverted induced fit"
- A 2-cysteine peroxiredoxin
- Pioneering in the field of peroxiredoxins
- The "new" peroxidase family: peroxiredoxins
- How does TXNPx interact?
- General reaction scheme of Prx
- Variations of the Prx reaction scheme
- The oxidative steps of the catalytic system
- Reaction scheme of TXNPx I: oxidative steps
- N-terminal catalytic triad of a Prx
- Inter-subunit disulfide formation in TXNPx
- The reductive steps of the catalytic system
- Reaction scheme of TXNPx 2: reductive steps
- TXN attacking TXNPx at the CR (C173')
- Using same tools to study TXN /TXNPx interaction
- Tryptic peptides linking TXNPx to TXN C44S
- Reduced TXNPx from T. cruzi
- Dead end intermediate of TXNPx and TXNC44S
- Modeling the intermediate to averaged EM images
- Shapes of Tb TXNPx
- MOLISA logo - molecular links of TXN and TXNPx
- Ranges of rate constants of Prx's
- Thiol-dependent hydroperoxide metabolism (1)
- Thiol-dependent hydroperoxide metabolism (2)
- Other functions of the T(SH)2 TXN couple
- Nothing works without trypanothione
- Where should the cycle be arrested?
- Validation of TryR as drug target
- Circumstantial evidence for therapeutic validity
- Inhibition of the biosynthesis of trypanothione
- Biosynthesis of trypanthione in trypanosomes
- Validation of TryS as drug target by dsRNAi
- Simulation of oxidative burst
- TryS-deficient T.brucei in oxidative challenge
- HTS for TryS inhibitors
- MOLISA's new paullone series of TryS inhibitors
- Summary
- Acknowledgements
- Thank you
Topics Covered
- Trypanosomes: causative agents of neglected diseases
- Uniqueness of redox metabolism in trypanosomes
- Detoxification of hydroperoxides and peroxynitrite
- Biosynthesis and function of trypanothione
- Validation of targets for trypanocidal drugs
Talk Citation
Flohe, L. (2007, November 1). How trypanosomes cope with oxidative stress [Video file]. In The Biomedical & Life Sciences Collection, Henry Stewart Talks. Retrieved December 3, 2024, from https://doi.org/10.69645/RYQH3138.Export Citation (RIS)
Publication History
Financial Disclosures
- Prof. Leopold Flohe has not informed HSTalks of any commercial/financial relationship that it is appropriate to disclose.